Parkinson’s Disease Therapeutics Market by Drug Class (Levodopa Combination, Dopamine Agonists, Monoamine Oxidase B (MAO-B) Inhibitors, Anticholinergic Drugs, Catechol-O-Methyltransferase (COMT) Inhibitors and Others), by Route of Adminstration (Oral, Transdermal, Subcutaneous, and Intestinal Infusion) and by Distribution Channel for Hospital Pharmacy, Retail Pharmacy and Online Sales: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2023

Global parkinson’s disease therapeutics market expected to generate revenue of around USD 4.31 billion by end of 2023, growing at a CAGR of around 10.6% between 2017 and 2023. Parkinson’s disease is a progressive movement disorder caused when dopamine-producing nerve cells function irregularly.

Request Brochure Request Discount

11-May-2018 | Number of pages: 110 | Report Code: ZMR-2858 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the Parkinson’s disease therapeutics market on a global and regional level. The study provides historic data of 2017 along with a forecast from 2018 to 2023 based revenue (USD Billion). The study includes drivers and restraints for the Parkinson’s disease therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Parkinson’s disease therapeutics market on a global level.

In order to give the users of this report a comprehensive view on the Parkinson’s disease therapeutics market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein drug class segment, route of administration segment and distribution channel segment is benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

Global Parkinson’s Disease Therapeutics Market

The study provides a decisive view on the Parkinson’s disease therapeutics market by segmenting the market based on drug class, route of administration, distribution channel, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2023. Based on drug class the market is segmented into levodopa combination, dopamine agonists, monoamine oxidase B (MAO-B) inhibitors, anticholinergic drugs, catechol-o-methyltransferase (COMT) inhibitors and others. Based on rote of administration the market is segmented into the oral, transdermal, subcutaneous, and intestinal infusion. Based on distribution channel the market is segmented into hospital pharmacy, retail pharmacy, and online sales. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East & Africa with its further bifurcation into major countries. This segmentation includes demand for Parkinson’s disease therapeutics market based on individual drug class, and distribution channel in all the regions and countries.

The report also includes detailed profiles of end players such as Novartis AG, F. Hoffmann-La Roche AG, AbbVie Inc., Teva Pharmaceutical Industries Ltd., UCB, Inc., STADA Arzneimittel AG, GlaxoSmithKline plc, Valeant Pharmaceuticals International, Inc., Merck & Co., Inc., Impax Laboratories, Inc., and Others.

This report segments the global Parkinson’s disease therapeutics market as follows:

Global Parkinson’s Disease Therapeutics Market: Drug Class Segment Analysis

  • Levodopa Combination
  • Dopamine Agonists
  • Monoamine Oxidase B (Mao-B) Inhibitors
  • Anticholinergic Drugs
  • Catechol-O-Methyltransferase (Comt) Inhibitors
  • Others

Global Parkinson’s Disease Therapeutics Market: Route of Administration Segment Analysis

  • Oral
  • Transdermal
  • Subcutaneous
  • Intestinal Infusion

Global Parkinson’s Disease Therapeutics Market: Distribution Channel Segment Analysis

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales

Global Parkinson’s Disease Therapeutics Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Image-guided Therapy Systems Market: by Product (Positron Emission Tomography (PET), Magnetic Resonance Imaging (MRI), and Others), Application (Oncology, Cardiology and Electrophysiology, Neurosurgery, and Others), and End-Use (Ambulatory Surgery Centers and Hospitals): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3377 | Report Format:

The report covers forecast and analysis for the image-guided therapy systems market on a global and regional level. The study provides historic data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the image-guided ther...Read More

Real World Evidence Solutions Market by Component (Data Sets and Services), by Therapeutic Area (Oncology, Cardiovascular Disease, Neurology, Immunology, and Others), and by End-Users (Pharmaceutical and Medical Device Companies, Healthcare Payers, Healthcare Providers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2026

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3365 | Report Format:

The report covers forecast and analysis for the real world evidence solutions market on a global and regional level. The study provides historic data for 2016 and 2017 along with a forecast from 2018 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the real wor...Read More

Oral Proteins and Peptides Market by Drug Type (Linaclotide, Plecanatide, Calcitonin, Insulin, and Octreotide) and by Application (Gastric & Digestive Disorders, Bone Diseases, Diabetes, Hormonal Disorders, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 – 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3360 | Report Format:

The report covers forecast and analysis for the oral proteins and peptides market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the oral prot...Read More

Medical Display Market by Technology (OLED, CCFL-Backlit LCD, and LED-Backlit LCD), by Display Color (Monochrome Displays and Color Displays), and by Resolution (Up to 2mp Resolution, 2.1–4mp Resolution, 4.1–8mp Resolution, and above 8mp Resolution), by Panel Size (Under-22.9-Inch, 23.0–26.9-Inch, 27.0–41.9-Inch, and Above-42-Inch), and by Application (Surgical, Diagnostic, Dentistry, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3358 | Report Format:

The report covers forecast and analysis for the medical display market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the medical display...Read More

Facial Rejuvenation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2024

Price : $ 3999.00 | Report Code: ZMR-3351 | Report Format:

Global Facial Rejuvenation Market: Overview Facial rejuvenation is a mixture of various medical and cosmetic procedures which are used in order to restore a youthful appearance to the human face. It can be achieved through non-invasive or minimally invasive surgical or non-surgical procedures. T...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.